FTSE All-Share

FTSE All-Share handeln
5.735,46 PKT +15,93 PKT +0,28 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
23.11.20 AstraZeneca overweight JP Morgan Chase & Co.
23.11.20 AstraZeneca Sell Goldman Sachs Group Inc.
23.11.20 AstraZeneca buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
23.11.20 AstraZeneca Sell UBS AG
23.11.20 AstraZeneca Hold Jefferies & Company Inc.
20.11.20 HSBC Neutral UBS AG
20.11.20 Barclays buy UBS AG
19.11.20 National Grid Neutral UBS AG
19.11.20 AstraZeneca buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.11.20 GSK buy Jefferies & Company Inc.
17.11.20 Vodafone Group overweight JP Morgan Chase & Co.
17.11.20 Vodafone Group buy UBS AG
17.11.20 Vodafone Group Outperform Credit Suisse Group
17.11.20 BP Sector Perform RBC Capital Markets
16.11.20 Diageo buy Goldman Sachs Group Inc.
16.11.20 Vodafone Group overweight JP Morgan Chase & Co.
16.11.20 Vodafone Group buy Jefferies & Company Inc.
16.11.20 Vodafone Group buy Goldman Sachs Group Inc.
13.11.20 National Grid buy Deutsche Bank AG
13.11.20 Diageo buy Goldman Sachs Group Inc.
13.11.20 GSK Equal-Weight Morgan Stanley
13.11.20 National Grid buy Jefferies & Company Inc.
12.11.20 National Grid Neutral Goldman Sachs Group Inc.
11.11.20 Diageo Outperform Bernstein Research
11.11.20 Diageo Hold Kepler Cheuvreux
11.11.20 Vodafone Group buy UBS AG
11.11.20 Diageo buy Jefferies & Company Inc.
11.11.20 Shell (ex Royal Dutch Shell) buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.11.20 AstraZeneca Sell Goldman Sachs Group Inc.
10.11.20 AstraZeneca overweight JP Morgan Chase & Co.
10.11.20 AstraZeneca Hold Jefferies & Company Inc.
10.11.20 London Stock Exchange (LSE) Outperform Credit Suisse Group
10.11.20 HSBC Underweight JP Morgan Chase & Co.
10.11.20 Barclays overweight JP Morgan Chase & Co.
10.11.20 Rio Tinto overweight JP Morgan Chase & Co.
10.11.20 Diageo Underweight JP Morgan Chase & Co.
09.11.20 AstraZeneca Sell Goldman Sachs Group Inc.
06.11.20 AstraZeneca Outperform Credit Suisse Group
05.11.20 AstraZeneca Sell UBS AG
05.11.20 AstraZeneca overweight JP Morgan Chase & Co.